Angus Pryor is the Founder and CEO of Dental Marketing Solutions. In April 2023, Dental Marketing Solutions won the Australian Dental Industry Award for Marketing on a second occasion, the first being in 2020.
Convened by the Australian Dental Industry Association (ADIA), the Australian Dental Industry Awards recognise excellence in the provision of quality products and services that support the work of dentists and allied oral healthcare professionals.
After receiving his latest award, Angus spoke with Australian Health Journal.
By his estimate he’s delivered over 10,000 hours of consulting to dentists in Australia and internationally. In addition to the ADIA awards, his company has been the recipient of a number of other industry awards.
To Angus marketing deals with human psychology as well being part science and part art. He proclaims, “If dentists are serious about growing their business, they need to take marketing seriously”.
Today, competition in the dental industry is at an all time high.
According to Angus, “For more than a decade now, the number of practising dentists has increased at a rate two and a half times faster than the Australian population.”
Further, Angus has seen specialists in the dental sphere getting less referrals from general practitioner dentists. As he explains, general practitioner dentists are now doing more implants in house, more wisdom teeth, and even orthodontics. For a heavily referral based business, this can significantly impact the practice.
He offers 3 options to counter this
- Seeking more referrals from other practices
- Marketing direct to consumers
- Delivering lots of education and constantly engaging general dental practice
Winning the Australian Dental Industry Award for Marketing has had a big impact to Dental Marketing Solutions. As Angus comments in closing, “Receiving the award is social proof to say, well, these guys must know something, because an independent body of their peers has assessed them and said”. He added, “Certainly it’s been good in terms of building our business.”
-
Growing impact of blood cancer on women
According to the Leukaemia Foundation, blood cancer is one of the most urgent and under-recognised women’s health issues in Australia, with three times more Australian women diagnosed with blood cancer than ovarian and cervical cancer combined (Source: AIHW, Cancer Data in Australia, 2024).
Blood cancer has also emerged as the second most common cancer diagnosed in Australian women overall – behind only breast cancer – and the leading cancer amongst girls and women under the age of 30 (Source: AIHW, Cancer Data in Australia, 2024).
-
Smart technology in wound care
Throughout her journey around wound care, Santosh Kaur was frustrated to see the simple gaps in wound care resulting in negative patient outcomes. Santosh is the founder of SmartHeal which launched in 2020.
SmartHeal replaces the nurses taking cumbersome manual measurements and manual sharing of important wound data with a no touch technique. It aims for healthcare professionals to have live remote access to wound data, make wound assessments and assist with speech to text notes thus saving time, cost and people. SmartHeal also aims to assist healthcare professionals in providing optimum wound care by analysing the wound tissue for infection, moisture and providing suggestions for suitable dressing.
-
Continuing education program leads to better conversations
Medicines Australia’s Continuing Education Program (CEP) is designed to educate medical representatives to a recognised industry standard. Dr Tristan Ling, CEP Academic Lead and Project Manager at the College of Health and Medicine, University of Tasmania talks about the 900 students that come through the program each year.
The CEP is primarily directed at medical representatives working within the prescription medicines industry, but is also recommended to people who may not be currently employed within the industry but would like to pursue a career as a medical representative. It is also available to personnel working for organisations interacting with the pharmaceutical industry.
